Endovascular treatment for chronic pulmonary hypertension

a focus on angioplasty for chronic thromboembolic pulmonary hypertension

Toru Satoh, Masaharu Kataoka, Takumi Inami, Haruhisa Ishiguro, Ryoji Yanagisawa, Nobuhiko Shimura, Yohei Shigeta, Hideaki Yoshino

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Introduction: Percutaneous transluminal pulmonary angioplasty (PTPA) was introduced for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) in the late 20th century, and first attempts in collective patients were made in 2001 with beneficial effects but a moderate amount of complications. It was refined around 2010, and has been recently established as an effective and safe treatment. Areas covered: The indication was originally inoperable CTEPH with peripheral lesions, but has now widened to symptomatic or hypoxic patients. The lesion is typically a meshwork-like structure of organized thrombi and is sometimes not seen as a stenosis angiographically, necessitating other means of investigation such as measurement of distal pressure. The technique to treat lesions is the same as for coronary angioplasty except in several ways. Expert commentary: The effects of PTPA are comparable to those of surgical endarterectomy, and the complications of reperfusion pulmonary edema and vascular injury are now controlled by several strategies and based on experience.

Original languageEnglish
Pages (from-to)1089-1094
Number of pages6
JournalExpert Review of Cardiovascular Therapy
Volume14
Issue number9
DOIs
Publication statusPublished - 2016 Sep 1

Fingerprint

Angioplasty
Pulmonary Hypertension
Lung
Endarterectomy
Vascular System Injuries
Lung Injury
Pulmonary Edema
Reperfusion
Pathologic Constriction
Thrombosis
Therapeutics
Pressure

Keywords

  • Balloon pulmonary angioplasty
  • chronic thromboembolic pulmonary hypertension
  • percutaneous transluminal pulmonary angioplasty
  • pressure wire
  • pulmonary edema
  • pulmonary endarterectomy
  • pulmonary injury
  • pulmonary stenosis

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Endovascular treatment for chronic pulmonary hypertension : a focus on angioplasty for chronic thromboembolic pulmonary hypertension. / Satoh, Toru; Kataoka, Masaharu; Inami, Takumi; Ishiguro, Haruhisa; Yanagisawa, Ryoji; Shimura, Nobuhiko; Shigeta, Yohei; Yoshino, Hideaki.

In: Expert Review of Cardiovascular Therapy, Vol. 14, No. 9, 01.09.2016, p. 1089-1094.

Research output: Contribution to journalReview article

Satoh, Toru ; Kataoka, Masaharu ; Inami, Takumi ; Ishiguro, Haruhisa ; Yanagisawa, Ryoji ; Shimura, Nobuhiko ; Shigeta, Yohei ; Yoshino, Hideaki. / Endovascular treatment for chronic pulmonary hypertension : a focus on angioplasty for chronic thromboembolic pulmonary hypertension. In: Expert Review of Cardiovascular Therapy. 2016 ; Vol. 14, No. 9. pp. 1089-1094.
@article{1ea299a9b1d843ce8c206b20eaa0941c,
title = "Endovascular treatment for chronic pulmonary hypertension: a focus on angioplasty for chronic thromboembolic pulmonary hypertension",
abstract = "Introduction: Percutaneous transluminal pulmonary angioplasty (PTPA) was introduced for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) in the late 20th century, and first attempts in collective patients were made in 2001 with beneficial effects but a moderate amount of complications. It was refined around 2010, and has been recently established as an effective and safe treatment. Areas covered: The indication was originally inoperable CTEPH with peripheral lesions, but has now widened to symptomatic or hypoxic patients. The lesion is typically a meshwork-like structure of organized thrombi and is sometimes not seen as a stenosis angiographically, necessitating other means of investigation such as measurement of distal pressure. The technique to treat lesions is the same as for coronary angioplasty except in several ways. Expert commentary: The effects of PTPA are comparable to those of surgical endarterectomy, and the complications of reperfusion pulmonary edema and vascular injury are now controlled by several strategies and based on experience.",
keywords = "Balloon pulmonary angioplasty, chronic thromboembolic pulmonary hypertension, percutaneous transluminal pulmonary angioplasty, pressure wire, pulmonary edema, pulmonary endarterectomy, pulmonary injury, pulmonary stenosis",
author = "Toru Satoh and Masaharu Kataoka and Takumi Inami and Haruhisa Ishiguro and Ryoji Yanagisawa and Nobuhiko Shimura and Yohei Shigeta and Hideaki Yoshino",
year = "2016",
month = "9",
day = "1",
doi = "10.1080/14779072.2016.1208083",
language = "English",
volume = "14",
pages = "1089--1094",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Expert Reviews Ltd.",
number = "9",

}

TY - JOUR

T1 - Endovascular treatment for chronic pulmonary hypertension

T2 - a focus on angioplasty for chronic thromboembolic pulmonary hypertension

AU - Satoh, Toru

AU - Kataoka, Masaharu

AU - Inami, Takumi

AU - Ishiguro, Haruhisa

AU - Yanagisawa, Ryoji

AU - Shimura, Nobuhiko

AU - Shigeta, Yohei

AU - Yoshino, Hideaki

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Introduction: Percutaneous transluminal pulmonary angioplasty (PTPA) was introduced for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) in the late 20th century, and first attempts in collective patients were made in 2001 with beneficial effects but a moderate amount of complications. It was refined around 2010, and has been recently established as an effective and safe treatment. Areas covered: The indication was originally inoperable CTEPH with peripheral lesions, but has now widened to symptomatic or hypoxic patients. The lesion is typically a meshwork-like structure of organized thrombi and is sometimes not seen as a stenosis angiographically, necessitating other means of investigation such as measurement of distal pressure. The technique to treat lesions is the same as for coronary angioplasty except in several ways. Expert commentary: The effects of PTPA are comparable to those of surgical endarterectomy, and the complications of reperfusion pulmonary edema and vascular injury are now controlled by several strategies and based on experience.

AB - Introduction: Percutaneous transluminal pulmonary angioplasty (PTPA) was introduced for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) in the late 20th century, and first attempts in collective patients were made in 2001 with beneficial effects but a moderate amount of complications. It was refined around 2010, and has been recently established as an effective and safe treatment. Areas covered: The indication was originally inoperable CTEPH with peripheral lesions, but has now widened to symptomatic or hypoxic patients. The lesion is typically a meshwork-like structure of organized thrombi and is sometimes not seen as a stenosis angiographically, necessitating other means of investigation such as measurement of distal pressure. The technique to treat lesions is the same as for coronary angioplasty except in several ways. Expert commentary: The effects of PTPA are comparable to those of surgical endarterectomy, and the complications of reperfusion pulmonary edema and vascular injury are now controlled by several strategies and based on experience.

KW - Balloon pulmonary angioplasty

KW - chronic thromboembolic pulmonary hypertension

KW - percutaneous transluminal pulmonary angioplasty

KW - pressure wire

KW - pulmonary edema

KW - pulmonary endarterectomy

KW - pulmonary injury

KW - pulmonary stenosis

UR - http://www.scopus.com/inward/record.url?scp=84983381706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983381706&partnerID=8YFLogxK

U2 - 10.1080/14779072.2016.1208083

DO - 10.1080/14779072.2016.1208083

M3 - Review article

VL - 14

SP - 1089

EP - 1094

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 9

ER -